Genome & Company (KOSDAQ: 314130)
South Korea
· Delayed Price · Currency is KRW
2,770.00
-125.00 (-4.32%)
Dec 19, 2024, 2:34 PM KST
Genome & Company Revenue
Genome & Company had revenue of 4.62B KRW in the quarter ending September 30, 2024, with 3.70% growth. This brings the company's revenue in the last twelve months to 24.09B, up 65.54% year-over-year. In the year 2023, Genome & Company had annual revenue of 14.30B with 1.50% growth.
Revenue (ttm)
24.09B
Revenue Growth
+65.54%
P/S Ratio
2.30
Revenue / Employee
240.90M
Employees
100
Market Cap
82.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.30B | 211.39M | 1.50% |
Dec 31, 2022 | 14.08B | 13.63B | 3,021.27% |
Dec 31, 2021 | 451.25M | 300.66M | 199.67% |
Dec 31, 2020 | 150.58M | 104.75M | 228.54% |
Dec 31, 2019 | 45.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition